(Q44624717)

4 December 2017

title

A blocking peptide for transforming growth factor-beta1 activation prevents hepatic fibrosis in vivo (English)

1 reference

4 December 2017

A blocking peptide for transforming growth factor-β1 activation prevents hepatic fibrosis in vivo (English)

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)00377-5

23 March 2024

author name string

Hiroki Kondou

1

1 reference

4 December 2017

Sotaro Mushiake

2

1 reference

4 December 2017

Yuri Etani

3

1 reference

4 December 2017

Yoko Miyoshi

4

1 reference

4 December 2017

Toshimi Michigami

5

1 reference

4 December 2017

Keiichi Ozono

6

1 reference

4 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14568256

23 March 2024

publication date

1 November 2003

1 reference

full work available at URL

4 December 2017

https://api.elsevier.com/content/article/PII:S0168827803003775?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)00377-5

https://api.elsevier.com/content/article/PII:S0168827803003775?httpAccept=text/plain

23 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)00377-5

23 March 2024

published in

Journal of Hepatology

1 reference

4 December 2017

volume

39

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

742-748

1 reference

Transforming growth factor beta in tissue fibrosis

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Complications of cirrhosis. I. Portal hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

TGF-beta latency: biological significance and mechanisms of activation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Role for carbohydrate structures in TGF-beta 1 latency

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Thrombospondin-1 is a major activator of TGF-beta1 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

1 reference

7 January 2021

The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Hepatocyte growth factor gene therapy of liver cirrhosis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Regulation of cell growth by redox-mediated extracellular proteolysis of platelet-derived growth factor receptor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900377-5

7 January 2021

Semiquantitative evaluation of hepatic fibrosis by measuring tissue hydroxyproline

15

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)00377-5

23 March 2024

Identifiers

1 reference

4 December 2017

1 reference